ILD medications: prednisolone, methylprednisolone, prednisone

ILD_CORTISONE

No definition available.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC H02AB0[6-7]|H02AB04

126176

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

57550

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

57550

diagram downward connector

Include endpoints None

57550

diagram downward connector
ILD_CORTISONE

Extra metadata

First used in FinnGen datafreeze DF3

Summary Statistics

Key figures

All Female Male
Number of individuals 57550 33920 23630
Unadjusted prevalence (%) 16.18 17.10 15.02
Mean age at first event (years) 51.24 47.87 56.08

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.03 1.99 [1.80, 2.20] 7.4e-41 7980
15 years 0.01 1.38 [1.27, 1.51] 2.2e-13 3620
5 years 0.00 2.64 [2.44, 2.85] <1e-100 2142
1 year 0.00 3.72 [3.29, 4.20] 1.5e-100 587

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: ILD_CORTISONE – ILD medications: prednisolone, methylprednisolone, prednisone
GWS hits:

Survival analyses between endpoints

Plot

before ILD medications: prednisolone, methylprednisolone, prednisone
after ILD medications: prednisolone, methylprednisolone, prednisone

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after ILD medications: prednisolone, methylprednisolone, prednisone